(Q80421997)

English

Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine

scientific article published on 01 August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

based on heuristic

inferred from title

immunologic adjuvant

1 reference

based on heuristic

inferred from title

anti-tetanus immunoglobulin

1 reference

based on heuristic

inferred from title

author name string

Masanori Isaka

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Takako Komiya

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Motohide Takahashi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Yoko Yasuda

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Tooru Taniguchi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Yanqiu Zhao

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Keiko Matano

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hideyuki Matsui

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jun-Ichi Maeyama

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kazunori Morokuma

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kunio Ohkuma

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Norihisa Goto

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kunio Tochikubo

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

23-24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3061-3068

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Measurement of antigen-specific mouse IgE by a fluorometric reverse (IgE-capture) ELISA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Tetanus antitoxin titration by haemagglutination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effective adjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Source and protective function of coproantibodies in intestinal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Host defense mechanisms at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Inhibition of Bacterial Adherence by Secretory Immunoglobulin A: A Mechanism of Antigen Disposal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Immune exclusion is a function of IgA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Antigenic specificity of antibodies in vaginal secretions during infection with Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Secretory IgA and bacterial adherence to nasal mucosal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: studies on the effect of vehicle volume

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.02.019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15297056%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80421997&oldid=1759536888"